Ocular Therapeutix, Inc. (OCUL)
Health Care ยท Pharmaceutical Preparations
Ocular Therapeutix, Inc. (OCUL) is listed on Nasdaq, where its shares have traded since July 25, 2014. SentiSense covers Ocular Therapeutix, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Pravin U. Dugel is its chief executive officer. The company reports 325 employees, and its corporate website is www.ocutx.com.
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Latest reported results
Ocular Therapeutix, Inc. reported revenue of $13.5 million for Q2 FY2026, up 0.1% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 254 institutions reported holding OCUL, with 204.6 million shares worth $2.0 billion in aggregate. The largest reported holders were FMR, Deep Track Capital and BlackRock. Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter.
More on OCUL
- OCUL sentiment: whether news and social coverage of Ocular Therapeutix, Inc. leans bullish or bearish, and the stories driving it.
- OCUL ownership: all 254 reporting institutions, plus insider and congressional trades.
- OCUL financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Ocular Therapeutix, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Ocular Therapeutix, Inc. do?
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye.
What sector is OCUL in?
SentiSense classifies Ocular Therapeutix, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does OCUL stock trade?
Ocular Therapeutix, Inc. (OCUL) is listed on Nasdaq, where its shares have traded since July 25, 2014.
Who is the CEO of Ocular Therapeutix, Inc.?
Pravin U. Dugel is the chief executive officer of Ocular Therapeutix, Inc..